| 1 | [SID115950086] | Active | AC50 | 0.03 | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity [AID540354, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 115950086 | | CID | 3245746 | | Outcome | Active | | AC50 | 0.03 [uM] | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity | | AID | 540354 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID115950086] | Active | AC50 | 0.128 | HDL Orthogonal Assay: Alexa 488-HDL Measured in Cell-Based System Using Plate Reader - 2085-03_Inhibitor_Dose_DryPowder_Activity [AID588777, Type: confirmatory] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 115950086 | | CID | 3245746 | | Outcome | Active | | AC50 | 0.128 [uM] | | BioAssay | HDL Orthogonal Assay: Alexa 488-HDL Measured in Cell-Based System Using Plate Reader - 2085-03_Inhibitor_Dose_DryPowder_Activity | | AID | 588777 | | BioAssay type | confirmatory | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 3 | [SID4252156] | Active | AC50 | 0.414 | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_CherryPick_Activity [AID493194, Type: confirmatory] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | AC50 | 0.414 [uM] | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_CherryPick_Activity | | AID | 493194 | | BioAssay type | confirmatory | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 4 | [SID4252156] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 5 | [SID4252156] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 6 | [SID115950086] | Active | AC50 | 96.96 | HDL Counter Assay: 3/24 Cytotox Measured in Cell-Based System Using Plate Reader - 2085-02_Inhibitor_Dose_DryPowder_Activity_Set5 [AID602126, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 115950086 | | CID | 3245746 | | Outcome | Active | | AC50 | 96.96 [uM] | | BioAssay | HDL Counter Assay: 3/24 Cytotox Measured in Cell-Based System Using Plate Reader - 2085-02_Inhibitor_Dose_DryPowder_Activity_Set5 | | AID | 602126 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID115950086] | Active | AC50 | 206.102 | HDL Counter Assay: 3/24 Cytotox Measured in Cell-Based System Using Plate Reader - 2085-02_Inhibitor_Dose_DryPowder_Activity [AID540246, Type: confirmatory] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 115950086 | | CID | 3245746 | | Outcome | Active | | AC50 | 206.102 [uM] | | BioAssay | HDL Counter Assay: 3/24 Cytotox Measured in Cell-Based System Using Plate Reader - 2085-02_Inhibitor_Dose_DryPowder_Activity | | AID | 540246 | | BioAssay type | confirmatory | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 8 | [SID4252156] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 9 | [SID4252156] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant [AID1530, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant | | AID | 1530 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 10 | [SID4252156] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant [AID1530, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant | | AID | 1530 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 11 | [SID4252156] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 12 | [SID4252156] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 13 | [SID4252156] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 14 | [SID4252156] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 15 | [SID4252156] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 16 | [SID4252156] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 17 | [SID4252156] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 18 | [SID4252156] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID4252156] | Inactive | Potency | 35.4813 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 20 | [SID4252156] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 21 | [SID4252156] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 22 | [SID4252156] | Inactive | Potency | | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 23 | [SID4252156] | Inactive | Potency | | qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II) [AID886, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II) | | AID | 886 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 24 | [SID4252156] | Inactive | IC50 | | High Throughput Screening Assay for Hsp70 Inhibitors [AID583, Type: confirmatory] | heat shock 70kDa protein 1A [Homo sapiens] [gi:123271505] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | High Throughput Screening Assay for Hsp70 Inhibitors | | AID | 583 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 1A [Homo sapiens] [gi:123271505] | | PubMed | | | Data Table |  |
|
| 25 | [SID4252156] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 26 | [SID4252156] | Inactive | | | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) [AID1845, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) | | AID | 1845 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 27 | [SID4252156] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) [AID875, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) | | AID | 875 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 28 | [SID4252156] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) [AID892, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) | | AID | 892 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 29 | [SID4252156] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 30 | [SID4252156] | Inactive | Potency | | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 31 | [SID4252156] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set [AID588497, Type: Literature] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | | AID | 588497 | | BioAssay type | Literature | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | 16604538 | | Data Table |  |
|
| 32 | [SID4252156] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 33 | [SID4252156] | Inactive | EC50 | | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells) [AID430, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells) | | AID | 430 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID4252156] | Inactive | EC50 | | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells) [AID431, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells) | | AID | 431 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID4252156] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID4252156] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 37 | [SID4252156] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. [AID1415, Type: screening] | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. | | AID | 1415 | | BioAssay type | screening | | Target | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] | | PubMed | | | Data Table |  |
|
| 38 | [SID4252156] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. [AID1415, Type: screening] | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. | | AID | 1415 | | BioAssay type | screening | | Target | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] | | PubMed | | | Data Table |  |
|
| 39 | [SID4252156] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. [AID1415, Type: screening] | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. | | AID | 1415 | | BioAssay type | screening | | Target | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] | | PubMed | | | Data Table |  |
|
| 40 | [SID4252156] | Inactive | Potency | | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID4252156] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID4252156] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID4252156] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID4252156] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID4252156] | Inactive | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID4252156] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID4252156] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID4252156] | Inactive | IC50 | | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 [AID588727, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 | | AID | 588727 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID4252156] | Inactive | Potency | | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID4252156] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 4252156 | | CID | 3245746 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|